Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
National Lung Screening Trial (NLST)
This study is ongoing, but not recruiting participants.
Sponsors and Collaborators: National Cancer Institute (NCI)
American College of Radiology Imaging Network
Information provided by: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT00047385
  Purpose

RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for lung cancer. It is not yet known whether helical CT scan is more effective than chest x-ray in reducing death from lung cancer.

PURPOSE: Randomized clinical trial to compare the effectiveness of helical CT scan with that of chest x-ray in screening individuals who are at high risk for developing lung cancer.


Condition Intervention
Lung Cancer
Procedure: bronchoscopic and lung imaging studies
Procedure: comparison of screening methods

MedlinePlus related topics: Cancer Lung Cancer X-Rays
U.S. FDA Resources
Study Type: Interventional
Study Design: Screening, Randomized, Active Control
Official Title: National Lung Screening Trial

Further study details as provided by National Cancer Institute (NCI):

Study Start Date: September 2002
Detailed Description:

OBJECTIVES:

  • Compare whether screening with low-dose helical CT scan vs chest x-ray reduces lung cancer-specific mortality in participants who are at high risk for developing lung cancer.

OUTLINE: This is a randomized, multicenter study. Participants are randomized to 1 of 2 screening arms.

  • Arm I: Participants undergo helical CT scan.
  • Arm II: Participants undergo chest x-ray. Participants in both arms undergo screening initially and then annually for 2 years.

Participants will then be contacted annually by mail or telephone for several years.

The National Lung Screening Trial (NLST) represents the union of two NCI-sponsored activities, the NCI Lung Screening Study I and the American College of Radiology Imaging Network (ACRIN). For more information, please access the ACRIN trial on Cancer.gov. The protocol ID is ACRIN-6654.

PROJECTED ACCRUAL: A total of 50,000 participants will be accrued for this study within 2 years.

  Eligibility

Ages Eligible for Study:   55 Years to 74 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

DISEASE CHARACTERISTICS:

  • Heavy smoker or former smoker (quit within last 15 years)
  • No prior cancer (other than nonmelanoma skin cancer or in situ cancer) within past 5 years

PATIENT CHARACTERISTICS:

Age

  • 55 to 74

Performance status

  • Not specified

Life expectancy

  • Not specified

Hematopoietic

  • Not specified

Hepatic

  • Not specified

Renal

  • Not specified

PRIOR CONCURRENT THERAPY:

Biologic therapy

  • Not specified

Chemotherapy

  • Not specified

Endocrine therapy

  • Not specified

Radiotherapy

  • Not specified

Surgery

  • Not specified
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00047385

  Show 37 Study Locations
Sponsors and Collaborators
American College of Radiology Imaging Network
Investigators
Study Chair: Christine D. Berg, MD NCI - Early Detection Research Group
Principal Investigator: Denise R. Aberle, MD Jonsson Comprehensive Cancer Center
  More Information

Clinical trial summary from the National Cancer Institute's PDQ® database  This link exits the ClinicalTrials.gov site
Web site for additional information  This link exits the ClinicalTrials.gov site

Publications of Results:
Publications indexed to this study:
Study ID Numbers: CDR0000257938, NCI-NLST, ACRIN-NCI-NLST
Study First Received: October 3, 2002
Last Updated: July 23, 2008
ClinicalTrials.gov Identifier: NCT00047385  
Health Authority: United States: Federal Government

Keywords provided by National Cancer Institute (NCI):
small cell lung cancer
non-small cell lung cancer

Study placed in the following topic categories:
Thoracic Neoplasms
Carcinoma, Small Cell
Non-small cell lung cancer
Respiratory Tract Diseases
Lung Neoplasms
Lung Diseases
Carcinoma, Non-Small-Cell Lung

Additional relevant MeSH terms:
Respiratory Tract Neoplasms
Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on January 30, 2009